1) I think Exosome Sciences (which by the way is not even wholly owned by Aethlon anymore) is another entity used by management to continue the ongoing 'pump...dilute...and repeat' scenario that we've seen for 16+ years where management gets enriched and the longtime shareholders get shafted.
2) I'm saying just enough of their research is valid to keep the sham going - that's the problem. There is nothing magical here - many companies are researching and creating products around exosomes, which were described for the first time over 30 years ago. Heck, go the Thermo Fisher's website and look at all the exosome capture kits you and I can buy today, to capture exosomes in Plasma, Urine, etc:
3) Management isn't inept; they're very good at perpetrating this sham. You don't uplist to the Nasdaq and continue to get funding without being savvy about money and markets. If you want a "tell" regarding JJ's intentions on the uplist, look no further than his comments after the announcement. I will paraphrase: "this will give us more access to capital markets". He didn't say "this will give our products more visibility" OR "this will help us sell more HPs" or even "this will assist us in forming strategic partnerships". His first reaction (and he probably regrets saying it) was related to getting more money from investors and continuing the pump...dilute...repeat.
4)Not angry at all. Just like to call them as I see them and if I can prevent someone from losing money, I'm happy.
In 16 years they've never sold a single HP. Not to a company. Not to a university. Not to a foeriegn country. Not to a guy in his garage. Contrast this with a real company like CTSO...compare their histories, successes and SALES. See what you think...
News 
Market Data 
Discover 
